Linc

Linc Interest Coverage

The Interest Coverage Ratio of Linc (LINC.ST) as of Nov 20, 2026 is -26.74. In the previous year, Interest Coverage Ratio was 62.42 — a change of -142.83% (lower).

Interest Coverage

-26.74

YoY

-142.83%

Last updated:

Interest Coverage Ratio of Linc is 2025 -26.74 . Interest Coverage Ratio of Linc was 2024 62.42 . It decreases by -142.83% lower compared to the previous year.

The Linc Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
252.61 SEK
Jan 1, 2019
1,710.91 SEK
Jan 1, 2020
4,110.39 SEK
Jan 1, 2021
-38.77 SEK
Jan 1, 2022
-357.23 SEK
Jan 1, 2023
37.17 SEK
Jan 1, 2024
62.42 SEK
Jan 1, 2025
-26.74 SEK
The Linc Interest Coverage history
YEARInterest CoverageYoY
-26.74-142.83%
62.42+67.94%
37.17-110.40%
-357.23+821.37%
-38.77-100.94%
4,110.39+140.25%
1,710.91+577.28%
252.61—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Interest Coverage Ratio of Linc is -26.74 in 2025.

Interest Coverage Ratio of Linc changed from 62.42 to -26.74, representing a -142.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Linc since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Linc with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Linc

All Key Metrics — Linc